Israel will begin testing its BriLife vaccine, which was developed at Israel Institute for Biological Research on healthy volunteers as soon as early November. “Our final goal is 15 million doses for the residents of the State of Israel and for our close neighbors,” said Prof. Shmuel Shapira, director of the IIBR. Yourway operates a local depot with 7,5000 sq ft of capacity in Tel Aviv, to easily service Israel and the Mid-East region.